Timing Is Everything: CAR T for Follicular Lymphoma

CAR T-cell therapy is the best option for patients with relapsed/refractory follicular lymphoma, even though it comes with serious side effects.

Related Keywords

Boston ,Massachusetts ,United States ,Dana Farber Cancer Institute ,New York ,Caron Jacobson ,Peter Martin ,Charalambos Babis Andreadis ,Great Debates ,Updates Hematologic Malignancies ,New York City ,Kite Pharma ,Newyork Presbyterian Hospital ,Weill Cornell Medicine ,Cart Cell ,California San Francisco ,Helen Diller Family Comprehensive Care ,Non Hodgkin 039s Lymphoma ,Non Hodgkin Lymphoma ,Hl ,Biologic Therapy ,Iologics ,Chimeric Antigen Receptort Cell Therapy ,Chimeric Antigen Receptors ,Himeric Immunoreceptors ,Himerict Cell Receptors ,Rtificialt Cell Receptors ,Art Chimaeric Antigen Receptort Cell Therapy Receptors Immunoreceptors Chimaerict ,Follicular Lymphoma ,Lymphoma ,